Riskpilot← Back to searchSign inGet full accessBL Hälsoinvest AB
ABActiveOrg 5567083570Sidvallsgatan 17Other human health activities n.e.c. · NACE 8699Est. 20061 employees
Revenue 2025
SEK 1,3M
-31% vs 2024
EBITDA margin
61.1%
+34% vs 2024
Equity ratio
60.2%
Financial strength
Net profit 2025
SEK 518K
+49% vs 2024
| Revenue | SEK 1,3M | -31% |
| EBITDA | SEK 781K | +34% |
| Net profit | SEK 518K | +49% |
| Total assets | SEK 1M | -11% |
| Equity | SEK 620K | +14% |
| Employees | 1 | — |
Legal name
BL Hälsoinvest AB
Org number
5567083570
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
14 augusti 2006
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva utredning, behandling och undervisning inom hälso- och sjukvård och därmed förenlig verksamhet. Bolaget skall även bedriva handel med värdepapper samt äga och förvalta fast egendom.
Address
Sidvallsgatan 17
Email
bengt.ljunglof@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 262 | 286 | 1 712 | 1 844 | 1 279 |
| Staff expenses | — | — | — | −1 128 | −293 |
| EBITDA | 211 | 209 | 598 | 585 | 781 |
| Depreciation & amort. | −0 | −0 | −77 | −106 | −106 |
| EBIT | 211 | 209 | 521 | 479 | 675 |
| Net financials | — | — | −32 | −40 | −23 |
| Profit before tax | 212 | 208 | 489 | 439 | 653 |
| Tax | −45 | −43 | −101 | −90 | −134 |
| Net profit | 167 | 165 | 388 | 349 | 518 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 448 | 547 | 1 453 | 1 159 | 1 031 |
| Equity | 340 | 380 | 643 | 542 | 620 |
| Long-term debt | 0 | 0 | 430 | 332 | 163 |
| Short-term debt | 108 | 167 | 380 | 284 | 248 |
| Total debt | 108 | 167 | 810 | 616 | 411 |
EBITDA margin
61.1%
This company
15.8%
Market median
+287% vs market
20212025
Equity ratio
60.2%
This company
38.2%
Market median
+58% vs market
20212025
Return on equity
83.5%
This company
18.4%
Market median
+354% vs market
20212025
Net profit margin
40.5%
This company
8.1%
Market median
+400% vs market
20212025
Asset turnover
1.24×
This company
1.12×
Market median
+11% vs market
20212025
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BL Hälsoinvest AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Einar Sven Ljunglöf | Deputy Board Member | 0 companies |
| Bengt Erik Ljunglöf | Board of Directors | 0 companies |